InvestSMART

Sigma Healthcare Limited (ASX:SIG)

ALERT: Price-sensitive ASX Announcement for SIG
Current share price for SIG : $2.930 -0.06 (-2.01%)+
Announcement
Release
26 Feb 2026 8:24AM
Price at Release
$2.990
Full Release
download
Summary
Sigma Healthcare Limited reported strong financial performance for the first half of FY26, with significant increases in revenue and earnings. Revenue rose by 14.9% to $5.5 billion, supported by growth in both domestic and international markets. The Normalised EBIT increased by 18.7%, driven by operating leverage and efficiency improvements. The company's strategic initiatives, including expanding their store network and product offerings, have been successful, contributing to a 19.2% rise in Normalised NPAT. Sigma is progressing well with its integration and synergy programs, achieving $13 million in synergies. The company is focused on continuing its growth strategy, with plans to further expand its international presence and enhance product differentiation.
Key Points
  • Sigma Healthcare reported a 14.9% increase in revenue for 1H26, reaching $5.5 billion.
  • The company achieved a Normalised EBIT of $582.9 million, an 18.7% increase from the previous period.
  • Normalised NPAT rose by 19.2% to $392.0 million.
  • Sigma's Gross Profit Margin was stable at 18.3%, driven by favorable mix and supplier support.
  • Operating expenses increased by 9.8%, with a focus on supporting domestic and international growth.
  • Sigma opened 12 new international stores, bringing the total to 97, with international sales up 24.5%.
  • The integration and synergy programs are on track with $13 million synergies realized so far.
  • Domestic like-for-like sales in Chemist Warehouse branded stores increased by 15.0%.
  • Sigma continues to expand its portfolio of owned and exclusive label products, contributing to revenue growth.
  • The company's strategic priorities include expanding their pharmacy franchise and enhancing product differentiation.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.